Duopharma Biotech Bhd (7148) — Working Capital to Net Assets Ratio
Duopharma Biotech Bhd (7148) has a Working Capital to Net Assets ratio of 66.7% as of December 2025. Working capital of RM505.45 Million (current assets of RM819.41 Million minus current liabilities of RM313.96 Million) is measured against net assets of RM757.62 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is Duopharma Biotech Bhd's balance sheet to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Duopharma Biotech Bhd Working Capital to Net Assets (2006–2025)
This chart shows how Duopharma Biotech Bhd's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2006 to 2025. As of December 2025, the ratio stands at 66.7%, reflecting working capital of RM505.45 Million against net assets of RM757.62 Million MYR. Check Duopharma Biotech Bhd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Duopharma Biotech Bhd (2006–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Duopharma Biotech Bhd from 2006 to 2025, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Duopharma Biotech Bhd market cap and net worth.
| Year | WC/NA Ratio | Working Capital (MYR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 66.7% | RM505.45 Million | RM757.62 Million | RM819.41 Million | RM313.96 Million | ▼ -10.8 pp |
| 2024 | 77.5% | RM549.62 Million | RM709.15 Million | RM727.05 Million | RM177.43 Million | ▲ +3.2 pp |
| 2023 | 74.3% | RM510.34 Million | RM687.12 Million | RM677.07 Million | RM166.73 Million | ▲ +32.0 pp |
| 2022 | 42.3% | RM276.90 Million | RM655.22 Million | RM541.49 Million | RM264.59 Million | ▼ -0.1 pp |
| 2021 | 42.4% | RM264.49 Million | RM624.00 Million | RM494.80 Million | RM230.31 Million | ▼ -5.7 pp |
| 2020 | 48.1% | RM309.37 Million | RM643.82 Million | RM459.69 Million | RM150.32 Million | ▲ +14.5 pp |
| 2019 | 33.6% | RM177.76 Million | RM529.75 Million | RM417.20 Million | RM239.44 Million | ▲ +3.4 pp |
| 2018 | 30.1% | RM144.88 Million | RM481.04 Million | RM367.33 Million | RM222.44 Million | ▼ -18.8 pp |
| 2017 | 49.0% | RM234.96 Million | RM479.87 Million | RM356.62 Million | RM121.66 Million | ▼ -8.9 pp |
| 2016 | 57.9% | RM263.03 Million | RM454.52 Million | RM366.18 Million | RM103.16 Million | ▼ -4.3 pp |
| 2015 | 62.2% | RM279.63 Million | RM449.72 Million | RM354.35 Million | RM74.71 Million | ▲ +19.1 pp |
| 2014 | 43.1% | RM83.51 Million | RM193.63 Million | RM106.85 Million | RM23.35 Million | ▲ +1.7 pp |
| 2013 | 41.4% | RM75.63 Million | RM182.65 Million | RM94.19 Million | RM18.55 Million | ▼ -0.1 pp |
| 2012 | 41.5% | RM70.75 Million | RM170.50 Million | RM92.62 Million | RM21.87 Million | ▼ -1.3 pp |
| 2011 | 42.8% | RM70.41 Million | RM164.44 Million | RM95.82 Million | RM25.41 Million | ▼ -2.7 pp |
| 2010 | 45.5% | RM71.86 Million | RM157.87 Million | RM96.23 Million | RM24.37 Million | ▼ -11.6 pp |
| 2009 | 57.1% | RM81.54 Million | RM142.74 Million | RM98.52 Million | RM16.98 Million | ▼ -3.4 pp |
| 2008 | 60.5% | RM78.97 Million | RM130.55 Million | RM95.01 Million | RM16.04 Million | ▲ +9.4 pp |
| 2007 | 51.1% | RM58.38 Million | RM114.21 Million | RM67.76 Million | RM9.38 Million | ▼ -12.5 pp |
| 2006 | 63.6% | RM92.53 Million | RM145.43 Million | RM103.27 Million | RM10.74 Million | — |